INS and metabolic dysfunction-associated steatotic liver disease: Inflammatory response and oxidative stress are two known key players during MASLD progression to MASH [106] by altering hepatic lipid metabolism, exacerbating insulin resistance, inducing ROS generation, modulating the proinflammatory response, and developing fibrosis [107].